Catalyst Wire Dossier Catalyst Wire Dossier

LymphoStat-B

belimumab · Human Genome Sciences
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for LymphoStat-B, covering 2012-06-25 to 2012-08-28. Get the full timeline:

Most recent: Clinical Trial Update: Safety and Efficacy Study of LymphoStat-B (Belimumab) in Subjects With Systemic Lupus Erythematosus (SLE) [Phase 2]

See pricing